Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Computed Tomography | Research article

Predictive factors for relapse of cryptogenic organizing pneumonia

Authors: Zenya Saito, Yugo Kaneko, Tsukasa Hasegawa, Masahiro Yoshida, Kyuto Odashima, Tsugumi Horikiri, Akira Kinoshita, Keisuke Saitoh, Kazuyoshi Kuwano

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

Relapse of cryptogenic organizing pneumonia (COP) may lead to poor long-term prognosis and necessitates multiple rounds of steroid treatment with potential adverse effects. The objective of this study is to identify predictive factors of COP relapse by comparing demographic and clinical variables between relapse and non-relapse groups.

Methods

During 2008–2013, 33 COP patients were treated, of which 23 (69.7%) and 10 patients (30.3%) were assigned to the non-relapse and relapse group, respectively. From medical records, we compared the following variables at initial episode: clinical characteristics, serum parameters, chest CT scan findings, and steroid treatment.

Results

Clinical characteristics, cumulative prednisone dose, and steroid treatment duration were similar between groups. In univariate analysis, alternatively, the proportion of patients with bilateral shadow pattern, traction bronchiectasis, and partial remission after steroid treatment was significantly higher in the relapse group. These differences were not significant by multivariate Cox regression analysis.

Conclusions

We identified radiographic findings, such as bilateral shadow pattern, traction bronchiectasis, and partial remission, may have possibility of predictive factors for COP relapse. Larger-scale studies are required to confirm if any are independent predictors of COP relapse.
Literature
1.
go back to reference Cottin V, Cordier JF. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med. 2012;33(5):462–75.CrossRef Cottin V, Cordier JF. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med. 2012;33(5):462–75.CrossRef
2.
go back to reference Crestani B, Valeyre D, Roden S, Wallaert B, Dalphin JC, Cordier JF. Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les maladies Orphelines Pulmonaires (GERM"O"P). Am J Respir Crit Care Med. 1998;158(6):1929–35.CrossRef Crestani B, Valeyre D, Roden S, Wallaert B, Dalphin JC, Cordier JF. Bronchiolitis obliterans organizing pneumonia syndrome primed by radiation therapy to the breast. The Groupe d'Etudes et de Recherche sur les maladies Orphelines Pulmonaires (GERM"O"P). Am J Respir Crit Care Med. 1998;158(6):1929–35.CrossRef
3.
go back to reference Epler GR. Heterogeneity of bronchiolitis obliterans organizing pneumonia. Curr Opin Pulm Med. 1998;4(2):93–7.CrossRef Epler GR. Heterogeneity of bronchiolitis obliterans organizing pneumonia. Curr Opin Pulm Med. 1998;4(2):93–7.CrossRef
4.
go back to reference Schwarz MI, King TE. Interstitial lung disease. 3rd ed. Hamilton, Ontario: B. C. Decker; 1998. viii, 760. Schwarz MI, King TE. Interstitial lung disease. 3rd ed. Hamilton, Ontario: B. C. Decker; 1998. viii, 760.
5.
go back to reference Cordier JF. Cryptogenic organising pneumonia. Eur Respir J Physiol. 2006;28(2):422–46.CrossRef Cordier JF. Cryptogenic organising pneumonia. Eur Respir J Physiol. 2006;28(2):422–46.CrossRef
6.
go back to reference Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest. 2011;139(4):893–900.CrossRef Drakopanagiotakis F, Paschalaki K, Abu-Hijleh M, Aswad B, Karagianidis N, Kastanakis E, Braman SS, Polychronopoulos V. Cryptogenic and secondary organizing pneumonia: clinical presentation, radiographic findings, treatment response, and prognosis. Chest. 2011;139(4):893–900.CrossRef
7.
go back to reference Yamamoto M, Ina Y, Kitaichi M, Harasawa M, Tamura M. Clinical features of BOOP in Japan. Chest. 1992;102(1 Suppl):21S–5S.CrossRef Yamamoto M, Ina Y, Kitaichi M, Harasawa M, Tamura M. Clinical features of BOOP in Japan. Chest. 1992;102(1 Suppl):21S–5S.CrossRef
8.
go back to reference Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest. 1992;102(3):715–9.CrossRef Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest. 1992;102(3):715–9.CrossRef
9.
go back to reference Watanabe K, Senju S, Wen FQ, Shirakusa T, Maeda F, Yoshida M. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest. 1998;114(6):1599–606.CrossRef Watanabe K, Senju S, Wen FQ, Shirakusa T, Maeda F, Yoshida M. Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest. 1998;114(6):1599–606.CrossRef
10.
go back to reference Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine. 1995;74(4):201–11.CrossRef Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine. 1995;74(4):201–11.CrossRef
12.
go back to reference Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM"O"P). Am J Respir Crit Care Med. 2000;162(2):571–7.CrossRef Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM"O"P). Am J Respir Crit Care Med. 2000;162(2):571–7.CrossRef
13.
go back to reference Davison AG, Heard BE, WA MA, Turner-Warwick ME. Cryptogenic organizing pneumonitis. Quart J Med. 1983;52(207):382–94.PubMed Davison AG, Heard BE, WA MA, Turner-Warwick ME. Cryptogenic organizing pneumonitis. Quart J Med. 1983;52(207):382–94.PubMed
14.
go back to reference Okada F, Ando Y, Honda K, Tanoue S, Matsumoto S, Mori H. Comparison of pulmonary CT findings and serum KL-6 levels in patients with cryptogenic organizing pneumonia. Brit J Radiol. 2009;82(975):212–8.CrossRef Okada F, Ando Y, Honda K, Tanoue S, Matsumoto S, Mori H. Comparison of pulmonary CT findings and serum KL-6 levels in patients with cryptogenic organizing pneumonia. Brit J Radiol. 2009;82(975):212–8.CrossRef
15.
go back to reference Nishino M, Mathai SK, Schoenfeld D, Digumarthy SR, Kradin RL. Clinicopathologic features associated with relapse in cryptogenic organizing pneumonia. Hum Pathol. 2014;45(2):342–51.CrossRef Nishino M, Mathai SK, Schoenfeld D, Digumarthy SR, Kradin RL. Clinicopathologic features associated with relapse in cryptogenic organizing pneumonia. Hum Pathol. 2014;45(2):342–51.CrossRef
16.
go back to reference Austin JH, Muller NL, Friedman PJ, Hansell DM, Naidichi DP, Remy-Jardin M, Webb WR, Zerhouni EA. Glossary of terms for CT of the lungs: recommendations of the nomenclature Committee of the Fleischner Society. Radiology. 1996;200(2):327–31.CrossRef Austin JH, Muller NL, Friedman PJ, Hansell DM, Naidichi DP, Remy-Jardin M, Webb WR, Zerhouni EA. Glossary of terms for CT of the lungs: recommendations of the nomenclature Committee of the Fleischner Society. Radiology. 1996;200(2):327–31.CrossRef
Metadata
Title
Predictive factors for relapse of cryptogenic organizing pneumonia
Authors
Zenya Saito
Yugo Kaneko
Tsukasa Hasegawa
Masahiro Yoshida
Kyuto Odashima
Tsugumi Horikiri
Akira Kinoshita
Keisuke Saitoh
Kazuyoshi Kuwano
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-018-0764-8

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.